Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer

The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Radu, Ionut-Cristian, Hudita, Ariana, Zaharia, Catalin, Stanescu, Paul O., Vasile, Eugenia, Iovu, Horia, Stan, Miriana, Ginghina, Octav, Galateanu, Bianca, Costache, Marieta, Langguth, Peter, Tsatsakis, Aristidis, Velonia, Kelly, Negrei, Carolina
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539237/
https://ncbi.nlm.nih.gov/pubmed/28824432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00508
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados